Who owns Pieris Pharmaceuticals?

Tip: Access positions for across all investors

Analyze quarterly positions in Pieris Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pieris Pharmaceuticals stock

Who bought or sold Pieris Pharmaceuticals this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 21M $3.8M 0% Dec 2023
 View chart
Lynx1 Capital Management 9.8M $1.8M 0% Dec 2023
 View chart
Citadel Advisors 1.3M $229k 108% Dec 2023
 View chart
BlackRock 1.0M $309k -1% Sep 2023
 View chart
Acadian Asset Management 962k $286k 65% Sep 2023
 View chart
Vanguard Group 907k $165k -12% Dec 2023
 View chart
Geode Capital Management 761k $227k 15% Sep 2023
 View chart
CM Management 750k $137k 15% Dec 2023
 View chart
Renaissance Technologies 381k $114k 3% Sep 2023
 View chart
State Street Corporation 223k $66k 0% Sep 2023
 View chart
Millennium Management 167k $30k -26% Dec 2023
 View chart
Northern Trust 138k $41k 0% Sep 2023
 View chart
Prudential Financial 110k $33k 834% Sep 2023
 View chart
Virtu Financial 90k $16k 100% Dec 2023
 View chart
Citigroup 89k $16k 0% Dec 2023
 View chart
Two Sigma Investments 41k $7.4k -3% Dec 2023
 View chart
Bank of New York Mellon 40k $7.3k 0% Dec 2023
 View chart
NorthStar Asset Management 39k $7.1k 100% Dec 2023
 View chart
Two Sigma Advisers 35k $6.3k 42% Dec 2023
 View chart
Tower Research Capital 31k $9.2k 26% Sep 2023
 View chart
Raymond James & Associates 30k $5.5k 0% Dec 2023
 View chart
NJ State Employees Deferred Compensation Plan 30k $5.5k 0% Dec 2023
 View chart
Goldman Sachs Group 23k $4.1k 0% Dec 2023
 View chart
Baader Bank 20k $2.7k 100% Dec 2023
 View chart
Commerce Bank N A 20k $3.6k 0% Dec 2023
 View chart
Kestra Advisory Services 18k $3.2k 100% Dec 2023
 View chart
Two Sigma Securities 15k $2.8k -15% Dec 2023
 View chart
Hudson Valley Investment Advisors 14k $2.4k 0% Dec 2023
 View chart
HPM Partners 10k $1.9k 100% Dec 2023
 View chart
Us Bancorp 10k $1.9k 0% Dec 2023
 View chart
Morgan Stanley 8.2k $2.4k 0% Sep 2023
 View chart
Group One Trading 6.7k $2.0k 0% Sep 2023
 View chart
UBS Group 6.3k $1.1k -86% Dec 2023
 View chart
Barclays 5.0k $1.0k 0% Dec 2023
 View chart
Wells Fargo & Company 4.8k $866.502000 -17% Dec 2023
 View chart
Cutler 4.5k $0 0% Dec 2023
 View chart
1620 Investment Advisors 4.4k $318k 100% Dec 2023
 View chart
Jpmorgan Chase & Co 2.0k $358.327800 -98% Dec 2023
 View chart
Rhumbline Advisers 1.9k $339.052200 0% Dec 2023
 View chart
Truvestments Capital 1.1k $333.984000 0% Sep 2023
 View chart
Royal Bank of Canada 572.00 $0 -82% Dec 2023
 View chart
Advisor Group Holdings 516.00 $94.015200 0% Dec 2023
 View chart
Hanson McClain Advisors 350.00 $64.015000 0% Dec 2023
 View chart
Bank of America Corporation 145.00 $25.998500 0% Dec 2023
 View chart
FMR 0 $0 -100% Sep 2023
 View chart

Who sold out of Pieris Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Aquilo Capital Management Sep 2023 3.3M $984k
Silverarc Capital Management Jun 2023 961k $159k
Hrt Financial Sep 2023 18k $5.0k
National Asset Management Sep 2023 17k $5.1k
Wealth Effects Sep 2023 12k $3.5k
Oppenheimer & Co Jun 2023 11k $1.7k
Tower View Investment Management & Research Sep 2023 1.0k $0